#1Cerebrolysin
A mixture of neuropeptides and amino acids used clinically (outside the US) in stroke and dementia research — the largest and most clinical-trial-heavy literature in this group.
Best peptides by research goal
Memory, focus, and neuroplasticity · 229 indexed studies
Best peptides for Cognitive Function
This goal covers peptides studied for effects on learning, memory consolidation, attention, and neuroprotection or neuroplasticity. It includes centrally-acting neuropeptides derived from ACTH/tuftsin fragments and larger neurotrophic peptide preparations.
Much of this literature comes out of Russian-language clinical research (Semax, Selank) with limited independent replication in Western journals, which is worth factoring in alongside the raw study count. Cerebrolysin has the largest and most clinically-oriented literature in the group, but it's a mixture of neuropeptides rather than a single defined compound, which changes what a purity claim on a COA can even mean.
For educational and research purposes only. Nothing here is medical advice; these compounds are not approved for human consumption outside prescription use.
Most-researched peptides
Ranked by indexed studies#2Noopept
A synthetic dipeptide-derived nootropic studied for memory enhancement and neuroprotective effects, mechanistically linked to AMPA/NMDA receptor modulation and BDNF/NGF signaling.
#3Semax
An ACTH-fragment analog studied in Russian clinical research for cognitive enhancement and neuroprotection, proposed to act via BDNF upregulation and monoaminergic modulation.
#4Selank
Same tuftsin-analog peptide as in the sleep goal; here relevant for its combined anxiolytic and mild nootropic profile, often studied alongside Semax.
#5Dihexa
Derived from angiotensin IV; studied preclinically for promoting synaptogenesis via the HGF/c-Met pathway, proposed for memory restoration in neurodegeneration models.
Frequently asked questions
Much of it was published in Russian-language journals and in small trials, with little independent replication. Study counts can overstate how settled the findings are.
Study counts are PubMed search-result totals checked on September 24, 2026 and will change as new literature is indexed — the linked search always reflects the current live count. Vendor counts come from the products VialCheck currently tracks. This is a research index, not an endorsement of any compound, vendor, or use.